Karyopharm Therapeutics
Price & Volume
Stats
See moreOpen | $6.97 |
Previous Close | $6.88 |
Day Range | $6.71-$6.99 |
52W Range | $3.51-$16.95 |
Market Cap | $59.6M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $137.2M |
Revenue Growth (YoY) | -11.4% |
Gross Profit (12 Mos) | $138.6M |
Diluted EPS | -$14.84 |
News
See moreYahoo Finance • 17 days ago
Biotech Stocks Surge After Hours: CAPR, TMDX Lead Gains Amid Trial Updates And Earnings Momentum
Yahoo Finance • last month
Top movers analysis in the middle of the day on 2025-08-15: top gainers and losers in today's session.
Yahoo Finance • 2 months ago
Karyopharm outlines $1B peak U.S. revenue opportunity in myelofibrosis with pivotal Phase III data expected by March 2026
Yahoo Finance • 2 months ago
Here are the major earnings before the open Monday
About
CEO | Mr. Richard A. Paulson M.B.A. |
CFO | Ms. Lori A. Macomber CPA |
Address | 85 Wells Avenue, Newton, MA, United States, 02459-3298 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 279 |
